Trinity Biotech PLC
NASDAQ:TRIB
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.09
3.46
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Trinity Biotech PLC
Trinity Biotech PLC
Net Issuance of Common Stock
Trinity Biotech PLC
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Trinity Biotech PLC
NASDAQ:TRIB
|
Net Issuance of Common Stock
-$270k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Medtronic PLC
NYSE:MDT
|
Net Issuance of Common Stock
-$4.2B
|
CAGR 3-Years
-117%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-12%
|
|
|
STERIS plc
NYSE:STE
|
Net Issuance of Common Stock
-$86.3m
|
CAGR 3-Years
-99%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Trinity Biotech PLC
Glance View
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The company operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.
See Also
What is Trinity Biotech PLC's Net Issuance of Common Stock?
Net Issuance of Common Stock
-270k
USD
Based on the financial report for Jun 30, 2024, Trinity Biotech PLC's Net Issuance of Common Stock amounts to -270k USD.
You don't have any saved screeners yet
